ATARA BIOTHERAPEUTICS, INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $375.00 thousand as of 2016-09-30, per its 10-Q filed 2016-11-04.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2016-11-04
- 2016-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $375.00K.
- 2016-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $747.00K.
- 2016-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $802.00K.
- 2015-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $156.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2016-09-30 | $375.00K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $747.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $802.00K 10-Q · filed 2016-05-06 |
| 2015-09-30 | $156.00K 10-Q · filed 2015-11-06 |
| 2014-09-30 | $31.90K 10-Q · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |